These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16567285)

  • 1. Recently diagnosed nonischemic dilated cardiomyopathy: when should we implant the defibrillator?
    Haqqani HM; Kalman JM
    Heart Rhythm; 2006 Apr; 3(4):404-5. PubMed ID: 16567285
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator.
    Takahashi A; Shiga T; Shoda M; Tanizaki K; Manaka T; Ejima K; Kasanuki H; Hagiwara N
    Heart Vessels; 2010 Mar; 25(2):150-4. PubMed ID: 20339977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more.
    Makati KJ; Fish AE; England HH; Tighiouart H; Estes NA; Link MS
    Heart Rhythm; 2006 Apr; 3(4):397-403. PubMed ID: 16567284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underdetection of ventricular tachycardia by an implantable cardioverter-defibrillator due to a locally prolonged arrhythmia cycle length.
    Lee IO; Ukena C; Böhm M; Buob A; Neuberger HR
    Clin Res Cardiol; 2013 Dec; 102(12):923-5. PubMed ID: 23887832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming.
    Koneru JN; Swerdlow CD; Wood MA; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):778-90. PubMed ID: 22010117
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Curnis A; Bontempi L; Dei Cas L
    Int J Cardiol; 2005 Aug; 103(2):207-8. PubMed ID: 16080982
    [No Abstract]   [Full Text] [Related]  

  • 10. Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?
    Jayachandran JV; Zipes DP
    J Am Coll Cardiol; 2003 May; 41(10):1713-5. PubMed ID: 12767652
    [No Abstract]   [Full Text] [Related]  

  • 11. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D; Lüthje L; Zabel M
    Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
    [No Abstract]   [Full Text] [Related]  

  • 12. Life-saving ICD activation in a high-risk early heart failure dilated cardiomyopathy patient. Is it time to reconsider our primary prevention approach?
    Gatzoulis KA; Arsenos P; Dilaveris P; Antoniou CK; Sideris S; Tousoulis D
    Hellenic J Cardiol; 2018; 59(4):238-240. PubMed ID: 28951196
    [No Abstract]   [Full Text] [Related]  

  • 13. Are implantable cardioverter defibrillators safe for people older than 75?
    Heart Advis; 2009 May; 12(5):8. PubMed ID: 20446360
    [No Abstract]   [Full Text] [Related]  

  • 14. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial.
    Rashba EJ; Estes NA; Wang P; Schaechter A; Howard A; Zareba W; Couderc JP; Perkiomaki J; Levine J; Kadish A
    Heart Rhythm; 2006 Mar; 3(3):281-6. PubMed ID: 16500299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrillator discharges in a young patient: what is the underlying arrhythmia?
    Kansal N; Healey JS; Morillo CA; Divakara Menon SM
    Heart Rhythm; 2014 Dec; 11(12):2202-5. PubMed ID: 25077708
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome.
    Spencer CT; Byrne BJ; Gewitz MH; Wechsler SB; Kao AC; Gerstenfeld EP; Merliss AD; Carboni MP; Bryant RM
    Pediatr Cardiol; 2005; 26(5):632-7. PubMed ID: 16235007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circadian and weekly distribution of malignant ventricular arrhythmias in patients with coronary heart disease or dilatative cardiomyopathy who have an implanted cardioverter-defibrillator].
    Wolpert C; Jung W; Spehl S; Schumacher B; Omran H; Schimpf R; Lüderitz B
    Dtsch Med Wochenschr; 1998 Feb; 123(6):140-5. PubMed ID: 9505952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pacing for prevention of ventricular arrhythmias: time for a pause.
    Wilber DJ
    Heart Rhythm; 2006 May; 3(5):581-2. PubMed ID: 16648065
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
    Wanahita N; Chen J; Bangalore S; Shah K; Rachko M; Coleman CI; Schweitzer P
    Am J Ther; 2012 Jan; 19(1):16-23. PubMed ID: 20720485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.